Nexentis Technologies market cap NXTS
Share price times shares outstanding: what the whole company sells for, since 2026.
- Today, Nov 2, 2026
- $772.3K
- Highest close in our data
- $4.2M
- Jun 2026
Nexentis Technologies is worth $772.3K at the close on Nov 2, 2026, at $0.53 a share.
It has traded since Jan 30, 2026, and over that time its market cap ranged from $761.8K in Oct 2026 to $4.2M in Jun 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $772.3K | $761.8K | $4.2M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Nexentis Technologies' size, closest first, today.
| Company | Market cap |
|---|---|
| NXTSNexentis Technologies | $772.3K |
| LNAILunai Bioworks | $830.7K |
| DCOYDecoy Therapeutics | $678.1K |
| ARTLArtelo Biosciences | $1.1M |
| SBFMSunshine Biopharma | $533.1K |
| GOVXGeoVax Labs | $1.2M |
| MTNBMatinas BioPharma | $1.3M |
| VBIOValion Bio | $471.2K |
| LABTLakewood-Amedex Biotherapeutics | $438.4K |
| KAPAKairos Pharma, LTD. | $1.6M |
| OGENOragenics | $1.7M |
| Peer median | $969.3K |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Nexentis Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.